Thursday, December 17, 2020

Rituximab – USA

 

On Dec. 16, 2020, Federal Circuit affirmed (Rule 36 judgment) PTAB finding method of use patent invalid as obvious.You can find the IPR details reported “"here"” on this blog.

No comments:

Post a Comment